Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)

Historical Holders from Q1 2021 to Q1 2025

Symbol
EWTX on Nasdaq
CUSIP
28036F105
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
93.9M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
98.9M
Holdings value
$2.64B
% of all portfolios
0.011%
Grand Portfolio weight change
0%
Number of holders
198
Number of buys
103
Number of sells
-79
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.004%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 5.5% $145M 5.16M Perceptive Advisors LLC Feb 13, 2025
JANUS HENDERSON GROUP PLC 5.3% $140M 4.98M JANUS HENDERSON GROUP PLC Dec 31, 2024
Paradigm Biocapital Advisors LP 5% $133M 4.74M Paradigm BioCapital Advisors LP Jan 27, 2025

Institutional Holders of Edgewise Therapeutics, Inc. - Common Stock, par value $0.0001 per share (EWTX)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 157K $3.45M +$668K $22.00 14
2024 Q4 98.9M $2.64B -$77.6M $26.70 198
2024 Q3 101M $2.7B -$13.8M $26.69 175
2024 Q2 102M $1.83B +$179M $18.01 138
2024 Q1 91.6M $1.67B +$309M $18.24 125
2023 Q4 79.6M $871M +$121M $10.94 115
2023 Q3 68.4M $392M -$8.24M $5.73 83
2023 Q2 69.5M $539M +$23.7M $7.75 93
2023 Q1 66.5M $443M -$749K $6.67 85
2022 Q4 66.4M $594M +$17.7M $8.94 88
2022 Q3 64.4M $633M +$133M $9.84 90
2022 Q2 48.9M $389M -$30.4M $7.96 72
2022 Q1 52.5M $510M +$35.1M $9.70 68
2021 Q4 50.2M $768M +$33.4M $15.28 56
2021 Q3 48M $796M +$3.11M $16.60 47
2021 Q2 47.9M $1.03B +$40.3M $21.33 46
2021 Q1 45.7M $1.48B +$1.48B $32.50 31